Evidence map›Paper›PMID 21460862›Full record

ReviewAsian journal of andrology2011

Prevalence and medical management of erectile dysfunction in Asia.

Kwangsung Park, Eu Chang Hwang, Sun-Ouck Kim

Open access · goldAbstract readReview
In one paragraph

Review in Asian journal of andrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Priapism in homozygous sickle cell patients: important clinical and laboratory associations.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2014
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kwangsung ParkDepartment of Urology, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju 501-757, Korea. uropark@gmail.com
Eu Chang Hwang
Sun-Ouck Kim
Chonnam National University · KRChonnam National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erectile dysfunction (ED) is an important worldwide health issue that has a significant negative impact on the quality of life and life satisfaction of both the affected individual and his partner. Here we review the prevalence of ED in Asia, associated factors that may influence sexual attitudes and sexual behaviours, and randomized clinical trials (RCTs) of phosphodiesterase-5 (PDE-5) inhibitors to evaluate the clinical efficacy and safety of PDE-5 inhibitors in Asian men. We searched for English-language articles in MEDLINE and PubMed from January 2000 to September 2010. Our results showed that the overall reported prevalence rate of ED in Asia ranged widely, from 2% to 88%. This finding indicates that ED is a common and major health problem in this region. However, sociocultural and economic factors in Asia prevent people from seeking and obtaining appropriate medical care. We found reports on five kinds of PDE-5 inhibitors for the management of ED: sildenafil, vardenafil, tadalafil, udenafil and mirodenafil. The results of RCTs showed that these five PDE-5 inhibitors are more effective than placebo in improving erectile function in Asian men with ED and that these drugs have similar efficacy and safety profiles.

Indexed as

AdultAgedAsiaBenzenesulfonamidesCarbolinesCyclic Nucleotide Phosphodiesterases, Type 5Drug-Related Side Effects and Adverse ReactionsErectile DysfunctionHumansImidazolesMaleMiddle AgedPhosphodiesterase 5 InhibitorsPiperazinesPrevalencePurinesBenzenesulfonamidesCarbolinesCyclic Nucleotide Phosphodiesterases, Type 5ImidazolesmirodenafilPhosphodiesterase 5 InhibitorsPiperazinesPurinesPyrimidinesPyrimidinonesSildenafil CitrateSulfonamidesSulfonesTadalafilTriazinesudenafilVardenafil Dihydrochloride

Identifiers

PMID21460862
PMCPMC3739634
OpenAlexW1971875952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.